- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
AstraZeneca Pharma India Ltd. (ASTR)
Track today's live AstraZeneca Pharma (ASTR) share price, performance and key data on this page with our current NSE:ASTR stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the AstraZeneca Pharma share price on the NSE exchange. Use the dropdown to switch exchange for the ASTR share price, head to our technical summary section, which provides analysis on AstraZeneca Pharma share price buy/sell indicators using real-time data (or discuss the AstraZeneca Pharma (ASTR) stock price today with other investors in the AstraZeneca Pharma NSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NSE:ASTR share price (ISIN: INE203A01020) to enhance your trading decisions with our free investment tools and resources.
What Is the AstraZeneca Pharma India Ltd. Share Price Today?
The AstraZeneca Pharma share price today is 8,191.00.
What Is the Stock Symbol for AstraZeneca Pharma India Ltd.
The stock symbol (or 'ticker') for AstraZeneca Pharma India Ltd. is "ASTR."
What Stock Exchange Does AstraZeneca Pharma India Ltd. Trade On?
AstraZeneca Pharma India Ltd. is listed and trades on the NSE stock exchange.
Is AstraZeneca Pharma India Ltd. a Good Stock to Buy?
Determining whether AstraZeneca Pharma (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NSE:ASTR share price (ISIN: INE203A01020) to enhance your trading decisions with our free investment tools and resources.
What Is the AstraZeneca Pharma India Ltd. Share Price Today?
The AstraZeneca Pharma share price today is 8,191.00.
What Is the Stock Symbol for AstraZeneca Pharma India Ltd.
The stock symbol (or 'ticker') for AstraZeneca Pharma India Ltd. is "ASTR."
What Stock Exchange Does AstraZeneca Pharma India Ltd. Trade On?
AstraZeneca Pharma India Ltd. is listed and trades on the NSE stock exchange.
Is AstraZeneca Pharma India Ltd. a Good Stock to Buy?
Determining whether AstraZeneca Pharma (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
8,191.00
+115.50(+1.43%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8,050.00
8,209.50
52 wk Range
7,551.50
9,849.50
ASTR is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8,050.008,209.50
52 wk Range
7,551.509,849.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.45%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.45%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
ASTR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Earnings
Latest Release
26/05/2026
EPS / Forecast
17.95 / --
Revenue / Forecast
5.85B / --
Compare ASTR to Peers and Sector
Metrics to compare | ASTR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipASTRPeersSector | |
|---|---|---|---|---|
P/E Ratio | 109.2x | 35.1x | −0.4x | |
PEG Ratio | 1.76 | 0.15 | 0.00 | |
Price/Book | 23.5x | 4.9x | 2.6x | |
Price / LTM Sales | 9.0x | 6.8x | 3.0x | |
Upside (Analyst Target) | - | 28.8% | 48.7% | |
Fair Value Upside | Unlock | 4.2% | 5.6% | Unlock |
AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally. It provides medicines for cardiovascular, renal, metabolic, and immunological conditions; oncology medicines under the TAGRISSO, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names; rare diseases medicines under the Koselugo brand name; and respiratory medicines under the Symbicort and Fasenra brand names. The company also offers medicines for diabetes; and clinical trial services. The company has a strategic collaboration with Leica Biosystems and Daiichi Sankyo Company, Limited for the development of an immunohistochemistry assay and an image analysis algorithm for the TROP2 NMR biomarker in non-small cell lung cancer. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the AstraZeneca Pharma (NSE: ASTR) Share Price Today?
The AstraZeneca Pharma stock price today is 8,191.00 INR.
What Stock Exchange Does AstraZeneca Pharma (ASTR) Trade On?
AstraZeneca Pharma is listed and trades on the India National Stock Exchange.
What Is the Ticker (Stock Symbol) for AstraZeneca Pharma?
The stock symbol (also called a 'ticker') for AstraZeneca Pharma is "ASTR."
Does AstraZeneca Pharma Pay Dividends? What’s The Current ASTR Dividend Yield?
Yes, ASTR Pays Dividends to its Shareholders. The current AstraZeneca Pharma dividend yield is 0.45%.
What Is the Current AstraZeneca Pharma Market Capitalisation?
As of today, AstraZeneca Pharma (NSE: ASTR) market cap is 204.70B INR.
What Is AstraZeneca Pharma's (ASTR) Earnings Per Share (TTM)?
The AstraZeneca Pharma EPS is currently 75.01 (Trailing Twelve Months).
When Is the Next AstraZeneca Pharma Earnings Date?
AstraZeneca Pharma's next earnings report will be released on 30/05/2026.
Is ASTR a Buy or Sell From a Technical Analyst Perspective?
Based on today's AstraZeneca Pharma moving averages and other technical indicators, the daily buy/sell signal for ASTR stock is Neutral.
How Many Times Has AstraZeneca Pharma Stock Split?
AstraZeneca Pharma has split 1 times. (See the ASTR stock split history page for full effective split date and price information.)
How Many Employees Does AstraZeneca Pharma Have?
AstraZeneca Pharma has 760 employees, based on their latest Companies House report.
What is the current trading status of AstraZeneca Pharma (NSE: ASTR)?
As of 08/08/2026, AstraZeneca Pharma (ASTR) is trading at a share price of 8,191.00 INR, with a previous close of 8,075.50 INR. The stock has fluctuated within a day range of 8,050.00 INR to 8,209.50 INR, while its 52-week range spans from 7,551.50 INR to 9,849.50 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.